Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06707090 · ClinicalTrials.gov registry record · Phase 3

Tissue Repair Gel in Venous Leg Ulcers (US)

A Phase 3 study of Venous Leg Ulcer and Wound Heal, sponsored by TR Therapeutics.

Recruiting
Registry status
Phase 3
Development phase
312
Enrollment target
20
Study locations

NCT06707090 is a Phase 3 study of Venous Leg Ulcer and Wound Heal that is actively recruiting participants, run by TR Therapeutics. The registered enrollment target is 312 participants, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06707090, a Phase 3 study of Venous Leg Ulcer and Wound Heal, is actively recruiting participants, sponsored by TR Therapeutics.

RECRUITING
Registry status
Phase 3
Development phase
312 participants
Enrollment target
20
Study locations

Study Summary

The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.

Conditions Studied

Venous Leg Ulcer Wound Heal Venous Ulcer Wounds Venous Stasis Venous Stasis Ulcer Non-healing Wound Venous Insufficiency of Leg

Interventions

  • OTHER Standard of care
  • DRUG TR987 0.1% gel + Standard of Care

Study Locations (20)

Florida

  • Clincial Research Site 47 - Deerfield Beach
  • Clincial Research Site 38 - Hollywood
  • Clincial Research Site 40 - Jacksonville
  • Clincial Research Site 19 - Miami
  • Clincial Research Site 26 - Miami
  • Clincial Research Site 13 - Pembrook Pines
  • Clincial Research Site 51 - Tamarac

California

  • Clincial Research Site 43C - Castro Valley
  • Clincial Research Site 14 - Fresno
  • Clincial Research Site 11 - Los Angeles
  • Clincial Research Site 43A - San Francisco
  • Clincial Research Site 43B - San Francisco
  • Clincial Research Site 54 - Vista

Illinois

  • Clincial Research Site 22 - Chicago
  • Clincial Research Site 34 - Chicago
  • Clincial Research Site 10 - O'Fallon
  • Clincial Research Site 49 - Springfield

Louisiana

  • Clincial Research Site 04 - Bossier City
  • Clincial Research Site 01 - Lafayette

Arizona

  • Clincial Research Site 21 - Tucson

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2025-01-28
Est. Completion 2028-02
Phase Phase 3

Sponsor

TR Therapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06707090

The ClinicalTrials.gov registry entry for NCT06707090 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher). The listed sponsor is TR Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT06707090 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Florida, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT06707090 about?

NCT06707090 is a clinical study titled "Tissue Repair Gel in Venous Leg Ulcers (US)". The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.

What is the current status of trial NCT06707090?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2025-01-28. Estimated completion is 2028-02.

What conditions does trial NCT06707090 study?

This clinical trial studies the following conditions: Venous Leg Ulcer, Wound Heal, Venous Ulcer, Wounds, Venous Stasis.

What interventions are being tested in trial NCT06707090?

The interventions under investigation include: Standard of care (OTHER), TR987 0.1% gel + Standard of Care (DRUG).

Who is sponsoring clinical trial NCT06707090?

This trial is sponsored by TR Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06707090 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Venous Leg Ulcer

All registered trials for this condition

Wound Heal

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.